Judson Englert
Chief Tech/Sci/R&D Officer at CYTEIR THERAPEUTICS, INC.
Judson Englert active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/05/2020 | - |
Career history of Judson Englert
Former positions of Judson Englert
| Companies | Position | Start | End |
|---|---|---|---|
| Medimmune, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Training of Judson Englert
| University of Pittsburgh | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- Judson Englert
- Experience
